Transition report pursuant to Rule 13a-10 or 15d-10

Note 10 - Stockholders' Deficit (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans

v3.19.2
Note 10 - Stockholders' Deficit (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans
4 Months Ended
Dec. 31, 2018
$ / shares
shares
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans [Abstract]  
Range of exercise prices $ 6.76
Number of options outstanding (in Shares) (in Shares) | shares 38,462
Weighted average remaining contractual life 4 years 357 days
Weighted average exercise price of outstanding options $ 6.76
number of options exercisable (in Shares) | shares 0
Weighted average exercise price of exercisable options $ 0